Business Description
Baird Medical Investment Holdings Ltd
ISIN : KYG0705H1039
Total Employee Number:
146Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | -0.79 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 0.02 | |||||
Beneish M-Score | -4.56 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.1 | |||||
3-Year FCF Growth Rate | 38.4 | |||||
3-Year Book Growth Rate | 11.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.56 | |||||
9-Day RSI | 42.38 | |||||
14-Day RSI | 40.5 | |||||
3-1 Month Momentum % | -46.74 | |||||
6-1 Month Momentum % | -4.85 | |||||
12-1 Month Momentum % | -54.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.7 | |||||
Quick Ratio | 1.66 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 126.96 | |||||
Days Sales Outstanding | 701.43 | |||||
Days Payable | 172.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 4.6 | |||||
Shareholder Yield % | -8.06 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.79 | |||||
Operating Margin % | -113.31 | |||||
Net Margin % | -121.04 | |||||
EBITDA Margin % | -108.86 | |||||
FCF Margin % | -6.15 | |||||
OCF Margin % | -5.96 | |||||
ROE % | -76.76 | |||||
ROA % | -36.43 | |||||
ROIC % | -45.94 | |||||
3-Year ROIIC % | -204.7 | |||||
ROC (Joel Greenblatt) % | -55.88 | |||||
ROCE % | -62.94 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.32 | |||||
PB Ratio | 1.04 | |||||
Price-to-Tangible-Book | 1.04 | |||||
EV-to-EBIT | -2.06 | |||||
EV-to-EBITDA | -2.16 | |||||
EV-to-Revenue | 2.35 | |||||
EV-to-FCF | -38.12 | |||||
| Price-to-Net-Current-Asset-Value | 1.96 | |||||
Earnings Yield (Greenblatt) % | -48.54 | |||||
FCF Yield % | -4.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BDMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baird Medical Investment Holdings Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22.537 | ||
| EPS (TTM) ($) | -0.98 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 224.3 | ||
| 14-Day RSI | 40.5 | ||
| 14-Day ATR ($) | 0.125603 | ||
| 20-Day SMA ($) | 1.10725 | ||
| 12-1 Month Momentum % | -54.42 | ||
| 52-Week Range ($) | 0.757 - 3.7499 | ||
| Shares Outstanding (Mil) | 31.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baird Medical Investment Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baird Medical Investment Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-16 | In 113 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 19 days | ||
| General meeting for 2025 | 2026-07-29 | In 3 days | ||
| Fourth quarter earnings results for 2025 | 2026-04-29 | 1.68 (-3.45%) | ||
| Annual report for 2025 | 2026-04-24 | 1.70 (-0.58%) | ||
| Annual report for 2024 | 2025-05-15 | 5.14 (+0.78%) |
Show
Entries
Baird Medical Investment Holdings Ltd Frequently Asked Questions
What is Baird Medical Investment Holdings Ltd(BDMD)'s stock price today?
The current price of BDMD is $1.06. The 52 week high of BDMD is $3.75 and 52 week low is $0.76.
When is next earnings date of Baird Medical Investment Holdings Ltd(BDMD)?
The next earnings date of Baird Medical Investment Holdings Ltd(BDMD) is 2026-08-14 Est..
Does Baird Medical Investment Holdings Ltd(BDMD) pay dividends? If so, how much?
Baird Medical Investment Holdings Ltd(BDMD) does not pay dividend.
Guru Commentaries on NAS:BDMD
No articles.
Press Release
Articles on Baird Medical Investment Holdings Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers